GlassScriptPhysician profile
Sylvia A Mohen
NPI 1962790907
$35,598.86
in general payments reported to CMS, 2019-2025
79 companies · $6,345 in 2025
The $6,345 reported for 2025 was more than what 86% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,422 · 2020: $3,307 · 2021: $5,719 · 2022: $5,292 · 2023: $5,737 · 2024: $6,777 · 2025: $6,345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $18K · Education: $386.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $18,472.23 |
| Education | $386.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $6,259.69 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $2,241.83 | 2019-2025 | Ajovy, Austedo Xr, Austedo Xr |
| Ucb, INC. | $2,105.20 | 2019-2025 | Briviact, Rystiggo, Nayzilam |
| Pfizer INC. | $1,922.58 | 2023-2025 | |
| Allergan, INC. | $1,423.53 | 2019-2022 | |
| Harmony Biosciences LLC | $1,384.87 | 2021-2025 | Wakix |
| Sk Life Science, INC. | $1,297.28 | 2020-2025 | |
| Lilly USA, LLC | $1,204.84 | 2019-2025 | Kisunla, Amyvid, Emgality |
| Amneal Pharmaceuticals LLC | $1,174.55 | 2019-2025 | Rytary, Lyvispah, Crexont |
| Mdd US Operations, LLC | $1,095.09 | 2019-2025 | Gocovri, Apokyn, Gocovri |
| Lundbeck LLC | $1,057.48 | 2020-2025 | Vyepti |
| Eisai INC. | $958.14 | 2020-2025 | |
| Neurelis, INC. | $912.37 | 2020-2025 | Valtoco |
| Biogen, INC. | $843.61 | 2020-2025 | Leqembi, Spinraza |
| Biohaven Pharmaceuticals, INC. | $818.78 | 2020-2021 |
Show all 79 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $771.55 | 2019-2023 | Aimovig |
| Biohaven Pharmaceutical Holding Company LTD. | $704.45 | 2022 | |
| Bausch Health US, LLC | $583.87 | 2019-2025 | Aplenzin, Wellbutrin |
| Takeda Pharmaceuticals U.S.A., INC. | $533.39 | 2020-2024 | Trintellix, Hyqvia |
| Merz Pharmaceuticals, LLC | $521.21 | 2021-2025 | Xeomin |
| Sunovion Pharmaceuticals INC. | $431.01 | 2019-2022 | |
| Avanir Pharmaceuticals, INC. | $421.65 | 2019-2022 | |
| Abbott Laboratories | $402.61 | 2019-2025 | Infinity |
| Supernus Pharmaceuticals, INC. | $393.09 | 2019-2024 | Qelbree |
| Novartis Pharmaceuticals Corporation | $359.53 | 2019-2021 | |
| Tg Therapeutics, INC. | $350.76 | 2023-2025 | |
| Kyowa Kirin, INC. | $324.77 | 2020-2024 | Nourianz |
| Axsome Therapeutics, INC. | $321.17 | 2023-2025 | Symbravo, Auvelity |
| Ipsen Biopharmaceuticals, INC | $269.06 | 2023-2025 | Dysport |
| Currax Pharmaceuticals LLC | $255.18 | 2020-2025 | Onzetra Xsail |
| Almatica Pharma LLC | $237.96 | 2021-2023 | Gralise |
| Zyla Life Sciences, INC. | $223.44 | 2019-2020 | |
| Boston Scientific Corporation | $217.06 | 2019-2023 | |
| Catalyst Pharmaceuticals, INC. | $181.09 | 2023-2024 | Fycompa, Firdapse |
| Corium, LLC | $179.81 | 2022-2023 | Adlarity |
| Neurocrine Biosciences, INC. | $161.94 | 2022-2025 | Ingrezza, Ongentys |
| Ge Healthcare | $160.30 | 2019-2025 | |
| Genzyme Corporation | $152.39 | 2019-2023 | |
| Alexion Pharmaceuticals, INC. | $144.42 | 2019-2025 | Ultomiris |
| Idorsia Pharmaceuticals US INC | $139.38 | 2022-2024 | Quviviq |
| Upsher-Smith Laboratories LLC | $135.90 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $128.44 | 2023-2024 | Aptiom |
| Assertio Therapeutics, INC. | $128.13 | 2020 | |
| Scilex Pharmaceuticals INC. | $124.92 | 2021-2025 | Ztlido |
| Argenx US, INC. | $120.43 | 2024-2025 | Vyvgart, Vyvgart Hytrulo |
| Medtronic, INC. | $119.69 | 2022-2025 | Percept PC Brainsense, Inceptiv |
| Grifols USA, LLC | $94.76 | 2022-2025 | Gamunex-C |
| Revance Therapeutics, INC. | $94.01 | 2024 | Daxxify |
| Otsuka America Pharmaceutical, INC. | $92.35 | 2023 | Nuedexta |
| Emd Serono, INC. | $92.34 | 2019-2020 | |
| Glaxosmithkline, LLC. | $88.37 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $88.22 | 2025 | Acthar |
| Celgene Corporation | $88.06 | 2021-2022 | |
| Horizon Therapeutics Plc | $82.91 | 2019-2021 | |
| Vertical Pharmaceuticals, LLC | $66.44 | 2019 | |
| Azurity Pharmaceuticals, INC. | $66.34 | 2024-2025 | Horizant |
| Jazz Pharmaceuticals INC. | $63.93 | 2021-2025 | |
| Acadia Pharmaceuticals INC | $59.41 | 2019-2025 | Nuplazid |
| Tonix Medicines, INC. | $56.47 | 2025 | Zembrace Symtouch |
| Greenwich Biosciences, INC. | $54.29 | 2020-2021 | |
| Brainsway USA INC | $48.40 | 2020 | |
| Vanda Pharmaceuticals INC. | $47.56 | 2025 | Ponvory |
| Janssen Biotech, INC. | $46.88 | 2025 | |
| Promius Pharma LLC | $46.31 | 2019 | |
| Octapharma USA, INC. | $44.25 | 2024 | Panzyga |
| Depuy Synthes Sales INC. | $43.08 | 2022-2025 | Orthovisc, Monovisc |
| Impel Pharmaceuticals LLC | $41.35 | 2025 | Trudhesa |
| Neuronetics, INC. | $35.42 | 2022 | |
| Edw Pharma, INC. | $35.11 | 2019 | |
| Avion Pharmaceuticals | $31.03 | 2023 | Methylphenidate Hydrochloride |
| Si-Bone, INC. | $26.29 | 2020 | |
| Averitas Pharma INC. | $24.80 | 2025 | Qutenza |
| Aquestive Therapeutics, INC. | $24.10 | 2022 | |
| Life Molecular Imaging LTD | $22.40 | 2025 | Neuraceq |
| Adlon Therapeutics L.P. | $22.29 | 2020 | |
| Janssen Pharmaceuticals, INC | $20.84 | 2022 | |
| Acorda Therapeutics, INC | $19.13 | 2019 | |
| Bioventus LLC | $18.74 | 2019 | |
| Merz North America, INC. | $14.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sylvia Mohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.